Resources
Glossary: GEO + LLM Monitoring for Pharma
Key terms and definitions for Generative Engine Optimization and LLM monitoring in pharmaceutical marketing. 38 terms covering everything from share-of-answer to MLR workflows.
A
- Action Queue / Governance Queue
- A workflow system that routes findings to accountable owners with due dates, priority levels, and audit trail.
- Why it matters for pharma teams: Findings without action are just noise. A governance queue ensures every issue has an owner, deadline, and documented resolution.
- AI Pulse Score
- A composite metric combining Visibility, Positioning, and Truth Alignment sub-scores to measure overall brand health in AI answers.
- Why it matters for pharma teams: A single score makes it easy to track trends, compare brands, and communicate status to leadership without deep-diving into details.
- Audit Trail
- A timestamped log of all findings, actions, and outcomes with evidence links and owner attribution.
- Why it matters for pharma teams: Regulated environments require documentation. An audit trail answers 'What did you find, what did you do, and when?' for any inquiry.
B
- Baseline
- An initial measurement establishing your brand's current performance across share-of-answer, positioning, and truth alignment before optimization.
- Why it matters for pharma teams: You can't prove improvement without a baseline. It captures the starting point so future measurements show delta and progress.
C
- Citation Quality
- An assessment of the authority and reliability of sources that AI cites when making claims about your brand.
- Why it matters for pharma teams: AI might cite peer-reviewed journals or random blogs equally confidently. Citation quality analysis reveals whether AI is using credible sources.
- Competitive Intelligence
- The practice of gathering and analyzing information about competitors to inform strategic decisions.
- Why it matters for pharma teams: In the AI layer, competitive intelligence means knowing how AI positions your competitors and what sources they're cited from.
- Content Footprint
- The breadth and depth of your brand's presence across the sources that AI systems use to generate answers.
- Why it matters for pharma teams: A larger content footprint means more chances for AI to find and cite your information. Thin content means AI relies on whatever it can find.
F
- Fair Balance
- The regulatory requirement that drug promotions present risk information with comparable prominence to benefit claims.
- Why it matters for pharma teams: If AI emphasizes benefits without mentioning risks, it violates fair balance principles - even if you didn't write the AI response.
G
- Generative Engine Optimization (GEO)
- The practice of optimizing content so that large language models (ChatGPT, Claude, Gemini, Perplexity) generate accurate, favorable, and well-cited answers about your brand.
- Why it matters for pharma teams: Unlike SEO which focuses on search rankings, GEO ensures AI systems represent your brand correctly. For pharma, this means approved claims, accurate safety info, and proper citations.
- Grounding
- The practice of connecting AI responses to specific, verifiable sources rather than generating from abstract training data.
- Why it matters for pharma teams: Well-grounded AI answers cite real sources. Poor grounding leads to hallucinations and invented facts about your brand.
H
- Hallucination
- When AI generates confident-sounding but factually incorrect information, such as inventing claims, studies, or side effects.
- Why it matters for pharma teams: Hallucinations in healthcare are dangerous. If AI invents a side effect or efficacy claim, patients and HCPs may act on false information.
- HCP Intent
- The underlying question or need driving a healthcare professional's query, such as dosing, drug interactions, clinical evidence, or guidelines.
- Why it matters for pharma teams: HCPs ask different questions than patients. Monitoring HCP intent patterns reveals whether AI is giving clinicians accurate, relevant information.
I
- Influence Graph
- A map of which domains and pages are shaping AI answers about your brand, showing citation frequency, domain authority, and context.
- Why it matters for pharma teams: AI doesn't create answers from nothing - it synthesizes from sources. Knowing which sources AI trusts helps you prioritize content publishing.
J
- Journey Stage
- The phase of the patient or HCP decision journey: awareness, consideration, decision, or ongoing management.
- Why it matters for pharma teams: AI answers may differ by journey stage. Early-stage queries need education; decision-stage queries need differentiation from competitors.
K
- Key Opinion Leader (KOL)
- A respected expert, often a physician or researcher, with significant influence in a therapeutic area.
- Why it matters for pharma teams: AI often cites KOL content. If a KOL publishes about your brand and AI picks it up, that influence compounds across millions of queries.
L
- Large Language Model (LLM)
- An AI system trained on massive text datasets to understand and generate human-like language (e.g., GPT-4, Claude, Gemini).
- Why it matters for pharma teams: LLMs power ChatGPT, Claude, Gemini, and Perplexity. Understanding what they are helps you understand why they sometimes get things wrong.
- LLM Monitoring
- The continuous tracking of how large language models describe, recommend, and cite your brand across real customer questions.
- Why it matters for pharma teams: Patients and HCPs increasingly ask AI for health information. Without monitoring, you won't know if AI is accurate, missing your brand, or citing competitors.
M
- Mention Rate
- The percentage of AI responses where your brand is mentioned, out of all relevant queries in the question set.
- Why it matters for pharma teams: Mention rate is the foundation of visibility. If you're only mentioned in 30% of relevant queries while competitors hit 70%, you have a gap.
- MLR (Medical-Legal Review)
- The internal approval process where promotional and educational materials are reviewed by Medical, Legal, and Regulatory representatives before publication.
- Why it matters for pharma teams: All pharma content must pass MLR. AI findings that require content changes need to flow through MLR, so audit trails and evidence are essential.
N
- Narrative Drift
- The gradual shift in how AI systems describe or frame your brand over time, often moving away from approved messaging or toward competitor language.
- Why it matters for pharma teams: Drift is subtle and cumulative. A small wording change can shift perceptions or introduce inaccuracies. Continuous monitoring catches drift before it compounds.
O
- Omnichannel Marketing
- A coordinated strategy providing customers with a unified, personalized experience across all channels and touchpoints.
- Why it matters for pharma teams: AI is now a channel. If your omnichannel strategy doesn't include AI monitoring, you have a visibility gap where customers are looking.
- On-Label / Off-Label
- On-label refers to uses approved by the FDA and included in the PI; off-label refers to uses not officially approved but sometimes practiced clinically.
- Why it matters for pharma teams: Pharma cannot promote off-label uses. If AI suggests your drug for an off-label indication, that's a compliance red flag requiring attention.
- OPDP (Office of Prescription Drug Promotion)
- The FDA division that monitors pharmaceutical advertising and promotion for compliance with regulations, issuing warning letters for violations.
- Why it matters for pharma teams: OPDP enforcement is real - they issue letters for overstated efficacy or missing risks. If AI spreads non-compliant claims, it could attract regulatory attention.
P
- Patient Intent
- The underlying question or need driving a patient's query, such as treatment options, side effects, cost, or access.
- Why it matters for pharma teams: Different intents lead to different AI answers. Understanding patient intent helps you target content where your brand should appear.
- PI-Backed Claim Defensibility
- The verification of AI-generated claims against your prescribing information (PI), categorizing claims as Supported, Ambiguous, or Not-in-PI.
- Why it matters for pharma teams: AI can hallucinate claims you never made. Verifying against PI catches inaccuracies and creates evidence for compliance review.
- Positioning
- How AI frames your brand relative to alternatives - first-line vs. second-line, premium vs. affordable, innovative vs. established.
- Why it matters for pharma teams: Positioning shapes perception. If AI positions your brand as 'older' or 'second choice,' that framing undermines marketing investment.
- Prescribing Information (PI)
- The FDA-approved document (package insert) containing official information about a drug's indications, dosage, warnings, contraindications, and side effects.
- Why it matters for pharma teams: PI is the source of truth for all approved claims. Any AI-generated statement should align with PI; anything beyond is a compliance risk.
- Prompt Engineering
- The practice of crafting AI queries to elicit specific types of responses, used in testing and optimization.
- Why it matters for pharma teams: Understanding how prompts affect AI responses helps design question sets that reveal real-world customer queries.
- Provider-Level Monitoring
- Tracking AI responses separately for each LLM provider (ChatGPT, Claude, Gemini, Perplexity) rather than aggregating across all.
- Why it matters for pharma teams: Each AI has different training data and source preferences. Provider-level views reveal where you're strong and where to focus improvements.
Q
- Question Set
- A standardized collection of questions designed to capture how AI responds to common patient and HCP queries about a therapeutic area or brand.
- Why it matters for pharma teams: Consistent question sets enable apples-to-apples comparison over time and across providers. Ad-hoc queries don't provide reliable trend data.
R
- Ranking Position
- Where your brand appears in AI-generated lists or comparisons - first, second, or buried at the end.
- Why it matters for pharma teams: Being mentioned is good; being mentioned first is better. Ranking position affects perception of leadership and preference.
- Re-test Loop
- The practice of re-running question sets after fixes are implemented to verify improvement and measure delta vs. baseline.
- Why it matters for pharma teams: AI answers change continuously. Without retesting, you won't know if your fixes worked or if new issues have emerged.
S
- Semantic Matching
- The AI technique of comparing meaning (not just keywords) between AI-generated claims and PI text to determine alignment.
- Why it matters for pharma teams: AI might rephrase PI claims. Semantic matching catches equivalent meanings even when wording differs, improving verification accuracy.
- Sentiment Analysis
- The process of determining whether text expresses positive, negative, or neutral attitudes.
- Why it matters for pharma teams: While AI Pulse focuses on accuracy, sentiment helps identify whether AI framing is favorable or unfavorable to your brand.
- Share-of-Answer
- A metric measuring how often your brand appears in AI responses compared to competitors, including mention rate, ranking position, and citation frequency.
- Why it matters for pharma teams: Share-of-answer is the new share-of-voice. If competitors appear in AI answers more often or in better positions, they're winning visibility where decisions are made.
- Source Authority
- A classification of citation sources as government (.gov), academic (.edu), commercial, or unknown, indicating trustworthiness.
- Why it matters for pharma teams: Government and academic sources carry more weight than commercial sites. If AI cites competitor marketing as authoritative, that's a problem.
T
- Token
- The basic unit of text that LLMs process, roughly equivalent to a word or word fragment.
- Why it matters for pharma teams: LLMs have token limits. Extremely long AI responses may be truncated, affecting where your brand appears in the answer.
- Truth Alignment
- The degree to which AI-generated statements about your brand match verified facts from PI and authoritative sources.
- Why it matters for pharma teams: Truth alignment is a sub-score in AI Pulse. Low truth alignment means AI is making claims that can't be verified - a compliance and reputation risk.